SG, Japan ink regulatory deal to fast-track medicine access by up to six months

It gives both entities a formal mechanism to collaborate.

Singapore's Health Sciences Authority (HSA) and Japan's Ministry of Health, Labour and Welfare (MHLW) signed a Memorandum of Cooperation (MOC) aiming to speed up access to new medicines.

The MOC covers collaboration in facilitating reliance on health products and Good Manufacturing Practice (GMP) inspections for pharmaceutical manufacturers.

The arrangement is expected to remove an average of three duplicative inspections per year and improve medicine access timelines by up to six months.

The MOC also gives both entities a formal mechanism to collaborate across different stages of the product lifecycle to strengthen regulatory reliance and support innovation.

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia